Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST:ANGEN)

Turkey flag Turkey · Delayed Price · Currency is TRY
9.81
+0.01 (0.10%)
At close: Jun 23, 2025, 6:00 PM GMT+3
-17.63%
Market Cap 2.16B
Revenue (ttm) 537.57M
Net Income (ttm) -241.08M
Shares Out 220.00M
EPS (ttm) -1.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,976,363
Average Volume 1,866,367
Open 9.78
Previous Close 9.80
Day's Range 9.60 - 10.10
52-Week Range 9.68 - 21.12
Beta -0.25
RSI 28.17
Earnings Date Aug 11, 2025

About IST:ANGEN

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid extraction kits, and automated NA extraction instrument kits. The company provides products for diseases, such as brucellosis, chlamydia trachomatis, cyto... [Read more]

Industry Medical Devices
Sector Healthcare
Employees 223
Stock Exchange Istanbul Stock Exchange
Ticker Symbol ANGEN
Full Company Profile

Financial Performance

In 2024, IST:ANGEN's revenue was 529.83 million, an increase of 54.06% compared to the previous year's 343.92 million. Losses were -218.88 million, 10.9% more than in 2023.

Financial Statements

News

There is no news available yet.